Senores Pharmaceuticals IPO Allotment Status

Summary

Senores Pharmaceuticals IPO has closed with an exceptional response from investors, achieving a remarkable final subscription of 97.86 times by December 24, 2024 at 6:19:11 PM (Day 3). The public issue demonstrated overwhelming investor interest across all categories, with the Non-Institutional Investors (NII) segment leading with 100.35 times subscription. The small NII category showed particularly strong enthusiasm with 111.35 times subscription, while the big NII portion achieved 95.25 times. The QIB category displayed robust interest with 97.84 times subscription, and the Retail category showed strong participation with 93.16 times subscription. The Anchor Investors portion was fully subscribed. This book built issue has attracted a total of 37,01,011 applications, indicating exceptional market interest in the company's pharmaceutical manufacturing business.

How to Check Senores Pharmaceuticals IPO Allotment Status:

How to Check Senores Pharmaceuticals IPO Allotment Status on the Registrar's Site?

Step 1: Visit the web portal of Link Intime India Private Ltd (https://linkintime.co.in/initial_offer/)
Step 2: From the dropdown menu, select Senores Pharmaceuticals IPO
Step 3: Choose one of the following modes: PAN ID, Demat Account number, or Application number
Step 4: Enter the information relevant to the mode you have chosen
Step 5: For security purposes, fill out the captcha accurately
Step 6:  Click "Submit"

How to Check Senores Pharmaceuticals IPO Allotment Status on BSE/NSE:

Step 1: Visit the BSE or NSE website (https://www.bseindia.com/investors/appli_check.aspx)
Step 2: Look for the IPO Allotment Status section
Step 3: Select "Senores Pharmaceuticals Limited" from the dropdown menu
Step 4: Enter your application number and PAN ID
Step 5: Click on 'I am not a robot' and then click "Search"

How to Check IPO Allotment Status in a Bank Account:

• Log into your Internet Banking: Go to your bank's website or mobile app and log in.
• Explore IPO Section: Locate the "IPO Services" or "Application Status" sections by going to the IPO Section. You can find this under the investing or services tab.
• Offer Required Information: You might be asked to provide information like your PAN, application number, or other identifiers.
• Verify Allotment Status: Once you submit your information, an IPO allotment status indicating the available allocation shares should appear.
• Verify Status: To ensure accuracy, you can verify the status with the IPO Registrar or use other resources.

How to Check IPO Allotment Status in a Demat Account? 

• Open Your Demat Account and Log in: To access your Demat account, use the mobile app or website of your Depository Participant (DP).
• Find IPO Section: Look for the section titled "IPO" or "Portfolio." 
• Verify IPO Allotment Status: Check if the allocated shares are visible in your Demat account.
• Verify with Registrar: If the IPO shares are inaccessible, visit the Registrar's website and enter your application data to verify allocation.
• Contact DP service if Needed: If there are any discrepancies or problems, contact your DP's customer service.

Senores Pharmaceuticals IPO Timeline:

Senores Pharmaceuticals IPO Subscription Status 

Senores Pharmaceuticals IPO received 97.86 times subscription with 37,01,011 applications. By December 24, 2024 at 6:19:11 PM (Day 3), the detailed subscription status revealed:

Subscription Day 3 (Final)

Total Subscription: 97.86 times
QIB: 97.84 times 
NII: 100.35 times
Retail investors: 93.16 times 

Subscription Day 2 (December 23, 2024)

Total Subscription: 14.65 times
QIB: 0.36 times
NII: 25.74 times (bNII: 20.70 times, sNII: 36.64 times)
Retail investors: 40.38 times

Subscription Day 1 (December 20, 2024)

Total Subscription: 1.94 times
QIB: 0.01 times
NII: 1.77 times (bNII: 1.13 times, sNII: 3.15 times)
Retail investors: 7.90 times
 

Senores Pharmaceuticals IPO Details 

Senores Pharmaceuticals' initial public offering (IPO) is a book built issue of ₹582.11 crores. This offering consists of a fresh issue of 1.28 crore shares aggregating to ₹500.00 crores and an offer for sale of 0.21 crore shares aggregating to ₹82.11 crores.

The bidding process commenced on December 20, 2024 and concluded on December 24, 2024. The allotment results are anticipated to be finalised on December 26, 2024. Furthermore, the shares of Senores Pharmaceuticals are set to be listed on BSE and NSE, with a provisional listing date scheduled for December 30, 2024.

The price band is set at ₹372-391 per share. Investors must apply for a minimum lot size of 38 shares, which requires a minimum investment of ₹14,858 for retail investors. For small NII (sNII), the minimum investment is 14 lots (532 shares), totalling ₹2,08,012, while for big NII (bNII), it is 68 lots (2,584 shares), totalling ₹10,10,344.

Equirus Capital Private Limited, Ambit Private Limited, and Nuvama Wealth Management Limited serve as the book running lead managers for the IPO, while Link Intime India Private Ltd is designated as the registrar for this offering.